Last Updated:
Name Designation Appointment Date Status
Ramesh Khurana

Appointed as Director since November 2011

Director 26-Nov-2011 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajesh Kumar Khurana

Appointed as Director since November 2011

Director 26-Nov-2011 Current
Surendra Kumar Yadav

Appointed as Director since June 2024

Director 26-Jun-2024 Current

People Timeline

Explore the timeline of key personnel in Gnosis Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address House No. B-102 First Floor Pushpanjali Enclave Pitampura, New Delhi Delhi, 110034, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Gnosis Pharmaceuticals Private Limited?
You can contact Gnosis Pharmaceuticals Private Limited through their registered address at House No. B-102 First Floor Pushpanjali Enclave Pitampura, New Delhi Delhi, 110034, India, or via their website at gnosispharma.com. Social media links are also provided where applicable.
Who are the current directors of Gnosis Pharmaceuticals Private Limited?
The current directors of Gnosis Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAMESH KHURANA
  • RAJESH KUMAR KHURANA
  • Surendra Kumar Yadav
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available